Approved Study Database

Ref. No. Scientific Title Principal investigator
2010.278 Hemoglobin Variability in Chinese Pre-Dialysis CKD Patients Not Reciving Erythropoietin Prof. SZETO Cheuk Chun
2013.564 A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis Prof. SZETO Cheuk Chun
2013.532 A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Efficacy and Safety of FG-4592 in the Treatment of Anemia in Incident-dialysis Patients Professor SZETO Cheuk Chun
2009.355 The Effect of Neutral Peritoneal Dialysis Solution With Minimal Glucose-Degradation-Product on the Fluid Status and Body Composition Prof. SZETO Cheuk Chun
2014.242 Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients Professor Szeto Cheuk Chun
2017.368 Urinary Sediment RNA Profile for the Prediction of Therapeutic Response in Lupus Nephritis Prof. SZETO Cheuk Chun
司徒卓俊
2014.482 A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy Prof. SZETO Cheuk Chun
2017.420 Urinary miRNA profile as the biomarker of IgA nephropathy Prof Szeto Cheuk Chun
司徒卓俊
2015.327 The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients with High Dialysis Effluent Bacterial DNA Fragment Levels Prof. SZETO Cheuk Chun
司徒卓俊
2016.480 Urinary RNA Levels as Prognostic Indicators of Chronic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2014.564 Urinary Podocyte mRNA as a Prognostic Marker of Diabetic Nephropathy Prof. SZETO Cheuk Chun
2014.352 Long Non-Coding RNA (IncRNA) in the Urinary Sediment of Patients with Chronic Kidney Disease Professor SZETO Cheuk Chun
2016.483 Cost-effectiveness analysis of screening of BK virus-associated nephropathy using urine cytology and serum quantitative polymerase chain reaction Prof. SZETO Cheuk Chun
司徒卓俊
2016.721 Urinary Mitochondrial DNA Level as a Biomarker of Chronic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2015.250 Genetic Determinants of Peritoneal Transport Characteristics and Cardiovascular Diseases for Peritoneal Dialysis Patients Prof. SZETO Cheuk Chun
司徒卓俊
2015.228 Relation Between Peritoneal Dialysis Effluent microRNA Level and Longitudinal Change in Peritoneal Transport Characteristics Prof. SZETO Cheuk Chun
司徒卓俊
2022.684 SGLT2 Inhibitor and DPP-4 Inhibitor for Podocyte Protection in Diabetic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2022.206 The Relation Between Glycemic Variability on Renal Mitochondrial Injury in Diabetic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2022.159 Optimization of Peritoneal Dialysis Prescription by Early Determination of Peritoneal Transport Characteristics Prof. SZETO Cheuk Chun
司徒卓俊
2022.125 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy Prof. SZETO Cheuk Chun
司徒卓俊
2023.247 A multicentered, single-group Phase 2, exploratory, open-label study to investigate safety and effect of sparsentan in combination with sodium glucose cotransporter-2 (SGLT2) inhibition in the treatment of adult participants with Immunoglobulin A nephropathy (IgAN) Prof. SZETO Cheuk Chun
司徒卓俊
2021.740 Fluid Overload as the Cause of Gut Permeability Barrier Dysfunction in Chronic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2021.738 Randomised, double-blind, placebo-controlled and parallel dose group trial to investigate efficacy and safety of multiple doses of oral BI 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetic and non-diabetic chronic kidney disease Prof. SZETO Cheuk Chun
司徒卓俊教授
2023.170 Development of a novel risk score for the prognosis of IgA nephropathy Prof. SZETO Cheuk Chun
司徒卓俊
2021.566 A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in patients with non-diabetic chronic kidney disease Prof. SZETO Cheuk Chun
2020.601 Optimization of Urine Processing for Biomarker Development of Kidney Diseases Prof. SZETO Cheuk Chun
司徒卓俊
2021.367 The Prognostic Role of Volume Overload in New Peritoneal Dialysis Patients Prof. SZETO Cheuk Chun
司徒卓俊
2021.020 A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function (The ALIGN Study) Prof. SZETO Cheuk Chun
司徒卓俊
2020.643 The Efficacy and Safety of SGLT2 Therapy in Advanced Diabetic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2021.163 Randomised, double-blind (within dose groups), placebo-controlled and parallel group trial to investigate the effects of different doses of oral BI 685509 given over 20 weeks on UACR reduction in patients with non-diabetic kidney disease Prof. SZETO Cheuk Chun
司徒卓俊
2023.363 Modified Creatinine Index as a Non-Invasive Tool for the Monitoring of Muscle Mass in Peritoneal Dialysis Prof. SZETO Cheuk Chun
Szeto Cheuk Chun
2010.375 Circulating Bacterial-Derived DNA Fragments in Peritoneal Dialysis Prof. SZETO Cheuk Chun
2010.173 Relation Between Intra-Renal Cytokine Expression and Histological Class of Lupus Nephritis Prof. SZETO Cheuk Chun
2009.479 Urinary Micro-RNA Profiling as a Prognostic Indicator of Chronic Kidney Diseases Prof. SZETO Cheuk Chun
2010.186 In-Depth Analysis of Patients Who Missed the Appointment of general Medical Clinic Prof. SZETO Cheuk Chun
2008.276 Genetic Determinants of Peritoneal Transport Characteristics, Peritonitis and Cardiovascular Risk for Chronic Peritoneal Dialysis Patients Prof. SZETO Cheuk Chun
2009.359 Bacteria-Derived DNA Fragment in Peritoneal Dialysis Effluent as a Predictor of Relapsing Peritonitis Prof. SZETO Cheuk Chun
2009.356 Circulating Bacterial-Derived DNA Fragments and Markers of Iinflammation in Peritoneal Dialysis Patients Prof. SZETO Cheuk Chun
2012.050 Long-Term Outcome of Biopsy-Proven Minimal-Change Nephrotic Syndrome in Adult Prof. SZETO Cheuk Chun
2012.048 Long-Term Outcome of Biopsy-Proven Minimal-Change Nephrotic Syndrome in Children Prof. SZETO Cheuk Chun
2009.188 The Effect of Neutral Peritoneal Dialysis Solution with Minimal Glucose-Degradation-Product on the Body Composition - A Cross-Sectional Study Prof. SZETO Cheuk Chun
2009.246 Outcome of Hemodialysis Patients Who had Failed Peritoneal Dialysis Prof. SZETO Cheuk Chun
2013.253 Intra-Renal and Urinary Th9 and Th22 Cytokine Gene Expression in Lupus Nephritis Prof. Szeto Cheuk Chun
2009.152 Urinary Micro-RNA Profiling for the Disease Monitoring of Systemic Lupus Erythematosus Prof. SZETO Cheuk Chun
2008.257 Monitoring of Urinary Messenger RNA Expression for the Prediction of Flare in Systemic Lupus Erythematosus Prof Szeto Cheuk Chun
2012.541 Circulating Mitochondrial-Derived DNA Fragments: A Possible Factor in the Pathophysiology of Systemic Inflammation and Cardiovascular Disease in Chronic Kidney Disease? Prof. SZETO Cheuk Chun
2013.530 Determining the Role of microRNA in Peritoneal Fibrosis by ex vivo Mesothelial Cell Culture from Peritoneal Dialysis Patients Professor Szeto Cheuk Chun
2008.378 Acute-on-Chronic Renal Failure: Indenticiation of Urinary Biomarkers for the Prediction of Reversibility Dr. SZETO Cheuk Chun
2012.311 Patients Who Default From Follow-up at Renal Specialist Clinic: Characteristics and Prognostic Implications Prof. SZETO Cheuk Chun
2012.542 Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis Prof. SZETO Cheuk Chun

Page 74 of 288.